DVA DaVita Inc. Common Stock
$179.90
Price · Aug 19, 2026
Fundamentals as of Aug 4, 2026
52W Range
$101–$247
54% of range
Analyst Rating
HOLD
13 analysts
Price Target
$218
+21% upside
P/E (TTM)
18.5
ROE
-281.8%
Net Profit Margin
5.5%
About DaVita Inc. Common Stock Company overview from Wikipedia
DaVita Inc., incorporated in Delaware and headquartered in Denver, provides kidney dialysis services through a network of 2,657 outpatient centers in the United States, serving 200,500 patients, and 585 outpatient centers in 14 other countries serving 94,500 patients. The company primarily treats end-stage renal disease (ESRD), which requires patients to undergo kidney dialysis, often 3 times per week for the rest of their lives unless they receive a kidney transplant via organ donation.
Read more
DaVita Inc. (a shortened contraction of "dare vita, meaning "to give life" in the Italian language), incorporated in Delaware and headquartered in Denver, provides kidney dialysis services through a network of 2,657 outpatient centers in the United States, serving 200,500 patients (36% of the total of 557,000 patients in the U.S.), and 585 outpatient centers in 14 other countries serving 94,500 patients. The company primarily treats end-stage renal disease (ESRD), which requires patients to undergo kidney dialysis, often 3 times per week for the rest of their lives unless they receive a kidney transplant via organ donation.
In 2025, 68% of the company's revenues came from Medicare and other government-based health insurance programs. In 2025, 89% of the company's patients were covered by government-based health insurance programs. Commercial payers, which accounted for 32% of revenues in 2025, generate nearly all of the company's profit as they reimburse at a much higher rate than government-based health insurance programs. The company is ranked 331st on the Fortune 500.
History
The company was founded in 1979 as Medical Ambulatory Care, Inc., a subsidiary of National Medical Enterprises, Inc. (now Tenet Healthcare).
In August 1994, 70% of the company was acquired by DLJ Merchant Banking Partners in a leveraged buyout for $75.5 million, including a $10.5 million investment by DLJ. The company then changed its name to Total Renal Care Holdings, Inc. In October 1995, the company became a public company via an initial public offering, raising $107 million. By December 1996, DLJ had made a 386% return on its $10.5 million investment.
Acquisitions and divestments
On February 27, 1998, the company acquired Renal Treatment Centers for $1.3 billion in stock. The integration went poorly and in July 1999, the CEO and CFO resigned. After tripling in value between 1995 and 1998, by July 1999, the stock price was down 71% year-to-date. In October 1999, Kent J. Thiry, then 43 years old, was named CEO.
In 2000, the company sold its non-U.S. operations. In October 2000, the company was renamed DaVita Inc. In October 2005, the company acquired Gambro Healthcare. In 2012, DaVita acquired Healthcare Partners for $4.42 billion, which was renamed DaVita Medical Group. In June 2019, the division was sold to UnitedHealth Group for $4.3 billion. In 2014, DaVita acquired Colorado Springs Health Partners, with 600 employees and 110,000 patients. In March 2016, it acquired the Everett Clinic Medical Group, a 20-site physicians practice with 315,000 patients in the Seattle area, for $385 million. In May 2017, it acquired WellHealth Quality Care.
Legal issues
In October 2014, the company agreed to pay $350 million to settle claims that it provided illegal kickbacks to doctors. In June 2015, the company agreed to pay $450 million to settle allegations that it unnecessarily disposed of drugs and then billed the U.S. federal government for this waste. In June 2018, a jury awarded the families of 3 of the company's patients $383 million in wrongful death claims after the patients died from cardiac arrest after undergoing treatment at DaVita centers. In October 2018, it agreed to pay $270 million to settle allegations that it violated the False Claims Act by providing inaccurate information that caused Medicare Advantage Plans to receive inflated payments. James Swoben, a whistleblower, received $10 million.
In July 2021, a federal grand jury indicted DaVita and former CEO Kent Thiry on charges of labor market collusion alleging participation in conspiracies with Surgical Care Affiliates to suppress competition for the services of certain senior-level employees. The company and Thiry were acquitted by a jury in April 2022. In October 2021, the Federal Trade Commission imposed limits on the company engaging in more mergers in Utah because of its history of buying up competitors.
In 2024, the Federal Trade Commission began investigating Davita along with Fresenius Medical Care under allegations they use illegal tactics to push smaller companies out of the market. In May 2025, the benefits fund of the United Food and Commercial Workers Local 1776 filed a proposed class-action lawsuit against DaVita and Fresenius Medical Care, a rival dialysis provider, alleging that the two companies illegally conspired to inflate treatment costs.
Source: Wikipedia, CC BY-SA 4.0 · View on Wikipedia ↗
DVA Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range
Price
$179.90
Market Cap
$12.45B
P/E (TTM)
18.5
EPS (TTM)
$9.84
Revenue (TTM)
$13.64B
Div Yield
0.00%
ROE
-281.8%
Debt/Equity
—
52W Range
$101 – $247
DVA Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
Configure
10-Year Performance Revenue, net income, margins and EPS trends
Revenue & Net Income
$13.64B
2016-12-31
→
2025-12-31
EPS
$9.84
2016-12-31
→
2025-12-31
Free Cash Flow
$1.31B
2016-12-31
→
2025-12-31
Margins
5.5%
Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?
Metric
5Y trend
DVA
Peer Median
P/E (TTM)
18.5
32.6
P/S (TTM)
0.9
2.0
P/B
-19.1
4.4
Price / FCF
9.5
—
Profitability Gross, operating and net margins; ROE, ROA, ROIC
Metric
5Y trend
DVA
Peer Median
Operating Margin
15.0%
—
Net Profit Margin
5.5%
2.4%
ROA
4.3%
4.5%
ROE
-281.8%
10.9%
ROIC
-245.6%
—
Financial Health Debt, liquidity, solvency — balance sheet strength
Metric
5Y trend
DVA
Peer Median
Current Ratio
1.3
1.7
Quick Ratio
1.0
—
Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR
Metric
5Y trend
DVA
Peer Median
Revenue YoY
6.5%
—
Revenue CAGR 3Y
5.5%
—
Revenue CAGR 5Y
3.4%
—
EPS YoY
-8.3%
—
Net Income YoY
-20.2%
—
Capital Efficiency Asset turnover, inventory turnover, receivables turnover
Metric
5Y trend
DVA
Peer Median
Payout Ratio
0.00%
—
Dividends Yield, payout ratio, dividend history, 5Y CAGR
Dividend Yield
0.00%
Payout Ratio
0.00%
5Y Div CAGR
—
DVA Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside
HOLD
13 analysts
- Strong Buy 1 7.7%
- Buy 5 38.5%
- Hold 6 46.2%
- Sell 1 7.7%
- Strong Sell 0 0.0%
12-Month Price Target
7 analysts · 2026-08-16
Median
$220.00
Now
$179.90
Low
$165.00
High
$270.00
Median target
$220.00
+22.3%
Mean target
$218.43
+21.4%
Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date
Avg Surprise
-0.04%
| Period | EPS Actual | EPS Est | Surprise |
|---|---|---|---|
| June 30, 2026 | $4.02 | $3.92 | 0.10% |
| March 31, 2026 | $2.87 | $2.34 | 0.53% |
| Dec. 31, 2025 | $3.40 | $3.19 | 0.21% |
| Sept. 30, 2025 | $2.04 | $3.25 | -1.2% |
| June 30, 2025 | $2.95 | $2.83 | 0.12% |
| March 31, 2025 | $2.00 | $1.97 | 0.03% |
Peer comparison (GICS sub-industry) Key metrics vs sector peers
| Ticker | Market Cap | P/E | Rev YoY | Net Margin | ROE | Gross Margin |
|---|---|---|---|---|---|---|
| DVA | $7.79B | 11.5 | 6.5% | 5.5% | -281.8% | — |
| DGX | $19.09B | 19.8 | 11.8% | 9.0% | 14.2% | — |
| LH | $20.62B | 24.0 | 7.2% | 6.3% | 10.3% | 28.8% |
| GH | $13.34B | -30.8 | 32.9% | -42.4% | 205.7% | — |
| LH | $20.62B | 24.0 | 7.2% | 6.3% | 10.3% | 28.8% |
| BTSG | $7.20B | 43.0 | 28.2% | 1.5% | 10.8% | 11.8% |
| HNGE | $0 | -6.0 | 50.6% | -89.9% | -299.8% | 79.7% |
| CHE | — | 23.3 | 4.1% | 10.5% | 24.4% | — |
| HIMS | — | 63.7 | 59.0% | 5.5% | 23.3% | 73.8% |
| RDNT | $5.28B | -285.4 | 11.5% | -0.91% | -1.9% | — |
| CVS | $100.87B | 57.1 | 7.8% | 0.44% | 2.4% | — |
Full Fundamentals All metrics by year — income statement, balance sheet, cash flow
Income Statement 13
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $13.64B | $12.82B | $12.14B | $11.61B | $11.62B | $11.55B | $11.39B | $11.40B | $10.88B | $10.71B | |
| SG&A Expense | $1.67B | $1.54B | $1.47B | $1.36B | $1.20B | $1.25B | $1.10B | $1.14B | $1.06B | $1.07B | |
| Operating Expenses | $11.60B | $10.73B | $10.54B | $10.27B | $9.82B | $9.86B | $9.75B | $9.88B | $9.06B | $8.68B | |
| Operating Income | $2.04B | $2.09B | $1.60B | $1.34B | $1.80B | $1.69B | $1.64B | $1.53B | $1.81B | $2.03B | |
| Other Non-op | $-103M | $-70M | $-19M | $-16M | $6M | $17M | $29M | $10M | $18M | $8M | |
| Pretax Income | $1.35B | $1.53B | $1.18B | $966M | $1.52B | $1.32B | $1.20B | $1.05B | $1.40B | $1.62B | |
| Income Tax | $293M | $280M | $220M | $198M | $307M | $314M | $280M | $258M | $324M | $432M | |
| Net Income | $747M | $936M | $692M | $560M | $978M | $774M | $811M | $159M | $664M | $880M | |
| EPS (Basic) | $10.06 | $11.02 | $7.62 | $6.03 | $9.30 | $6.46 | $5.29 | $0.93 | $3.52 | $4.36 | |
| EPS (Diluted) | $9.84 | $10.73 | $7.42 | $5.85 | $8.90 | $6.31 | $5.27 | $0.92 | $3.47 | $4.29 | |
| Shares (Basic) | 74,227,000 | 84,991,000 | 90,790,000 | 92,992,000 | 105,230,000 | 119,797,000 | 153,181,000 | 170,786,000 | 188,625,559 | 201,641,173 | |
| Shares (Diluted) | 75,885,000 | 87,274,000 | 93,182,000 | 95,834,000 | 109,948,000 | 122,623,000 | 153,812,000 | 172,365,000 | 191,348,533 | 204,904,656 | |
| EBITDA | $2.75B | $2.81B | $2.34B | $2.06B | $2.47B | $2.31B | $2.24B | $2.10B | $2.36B | $2.44B |
Balance Sheet 27
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $676M | $795M | $380M | $244M | $462M | $325M | $1.10B | $323M | $508M | $675M | |
| Short-term Investments | $24M | $51M | $12M | $78M | $22M | $20M | $12M | $3M | $33M | $307M | |
| Receivables | $2.41B | $2.15B | $1.99B | $2.13B | $1.96B | $1.82B | $1.80B | $1.86B | $1.71B | $1.50B | |
| Inventory | $161M | $135M | $143M | $109M | $107M | $112M | $98M | $107M | $182M | $160M | |
| Prepaid Expense | $156M | $123M | $103M | $79M | $73M | $76M | $67M | $112M | $112M | $100M | |
| Other Current Assets | · | · | · | · | · | · | · | · | $112M | $100M | |
| Current Assets | $4.06B | $3.75B | $3.14B | $3.16B | $3.17B | $3.15B | $3.69B | $8.42B | $8.77B | $3.99B | |
| PP&E (Net) | $2.81B | $2.94B | $3.07B | $3.26B | $3.48B | $3.52B | $3.47B | $3.39B | $3.15B | $2.86B | |
| PP&E (Gross) | $9.42B | $9.20B | $8.83B | $8.52B | $8.24B | $8.00B | $7.44B | $6.92B | $6.25B | $5.56B | |
| Accum. Depreciation | $6.60B | $6.26B | $5.76B | $5.27B | $4.76B | $4.48B | $3.97B | $3.52B | $3.10B | $2.70B | |
| Goodwill | $7.55B | $7.38B | $7.11B | $7.08B | $7.05B | $6.92B | $6.79B | $6.84B | $6.61B | $6.02B | |
| Intangibles | $222M | $197M | $203M | $183M | $178M | $167M | $136M | $119M | $114M | $74M | |
| Other Non-current Assets | $247M | $262M | $271M | $316M | $137M | $80M | $116M | $72M | $47M | $34M | |
| Total Assets | $17.48B | $17.29B | $16.89B | $16.93B | $17.12B | $16.99B | $17.31B | $19.11B | $18.97B | $18.76B | |
| Accounts Payable | $696M | $547M | $515M | $480M | $402M | $434M | $404M | $463M | $509M | $457M | |
| Current Liabilities | $3.14B | $2.97B | $2.64B | $2.62B | $2.40B | $2.48B | $2.37B | $4.89B | $3.07B | $2.71B | |
| Capital Leases | $2.18B | $2.21B | $2.33B | $2.50B | $2.67B | $2.74B | $2.72B | $0 | · | · | |
| Deferred Tax | $757M | $665M | $726M | $783M | $831M | $810M | $578M | $563M | $486M | $531M | |
| Other Non-current Liabilities | $84M | $170M | $183M | $105M | $119M | $150M | $161M | $451M | $365M | $317M | |
| Total Liabilities | $16.32B | $15.19B | $14.15B | $14.70B | $14.75B | $14.09B | $13.81B | $14.08B | $13.08B | $12.93B | |
| Common Stock | $69.0K | $90.0K | $89.0K | $90.0K | $97.0K | $110.0K | $126.0K | $166.0K | $182.0K | $195.0K | |
| Retained Earnings | $-328M | $1.53B | $598M | $174M | $354M | $853M | $1.43B | $2.74B | $3.63B | $3.71B | |
| Treasury Stock | $200M | $1.39B | $0 | · | $0 | $0 | $0 | $0 | $0 | $0 | |
| AOCI | $-123M | $-311M | $-52M | $-69M | $-139M | $-66M | $-47M | $-35M | $13M | $-90M | |
| Stockholders' Equity | $-651M | $121M | $1.06B | $712M | $756M | $1.38B | $2.13B | $3.70B | $4.69B | $4.65B | |
| Liabilities + Equity | $17.48B | $17.29B | $16.89B | $16.93B | $17.12B | $16.99B | $17.31B | $19.11B | $18.97B | $18.76B | |
| Shares Outstanding | 68,549,000 | 90,369,000 | 88,824,000 | 90,411,000 | 97,289,000 | 109,933,000 | 125,843,000 | 166,387,000 | 182,462,000 | 194,554,000 |
Cash Flow 17
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $708M | $716M | $736M | $721M | $668M | $617M | $601M | $575M | $544M | $495M | |
| Stock-based Comp | $140M | $103M | $112M | $95M | $102M | $91M | $68M | $73M | $35M | $38M | |
| Deferred Tax | $87M | $-58M | $-39M | $-76M | $60M | $241M | $42M | $274M | $-395M | $52M | |
| Amort. of Intangibles | $7M | $7M | $9M | $11M | $13M | $14M | $14M | $16M | $16M | $15M | |
| Other Non-cash | $205M | $324M | $558M | $263M | $122M | $256M | $551M | $691M | $1.06B | $447M | |
| Operating Cash Flow | $1.89B | $2.02B | $2.06B | $1.56B | $1.93B | $1.98B | $2.07B | $1.77B | $1.91B | $1.97B | |
| CapEx | $576M | $555M | $568M | $603M | $641M | $675M | $767M | $987M | $905M | $829M | |
| Investing Cash Flow | $-655M | $-771M | $-772M | $-630M | $-785M | $-825M | $3.00B | $-1.01B | $-1.36B | $-1.20B | |
| Debt Issued | $5.61B | $6.62B | $2.47B | $2.39B | $1.62B | $4.05B | $38.53B | $59.93B | $50.99B | $51.99B | |
| Net Debt Issued | $5.61B | $6.62B | $2.47B | $2.39B | $1.62B | $4.05B | $38.53B | $59.93B | $50.99B | $51.99B | |
| Stock Repurchased | $1.31B | $1.39B | $272M | $802M | $1.54B | $1.46B | $2.38B | $1.16B | $803M | $1.10B | |
| Net Stock Activity | $-1.31B | $-1.39B | $-272M | $-802M | $-1.54B | $-1.46B | $-2.38B | $-1.16B | $-803M | $-1.10B | |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | · | · | |
| Financing Cash Flow | $-1.37B | $-817M | $-1.17B | $-1.12B | $-1.08B | $-1.85B | $-4.70B | $-625M | $-766M | $-1.35B | |
| Net Change in Cash | $-122M | $415M | $126M | $-216M | $53M | $-707M | $369M | $137M | $-218M | $-577M | |
| Taxes Paid | $177M | $388M | $268M | · | · | · | · | · | · | · | |
| Free Cash Flow | $1.31B | $1.47B | $1.49B | $961M | $1.29B | $1.30B | $1.31B | $785M | $1.00B | $1.13B |
Profitability 7
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 15.0% | 16.3% | 13.2% | 11.5% | 15.5% | 14.7% | 14.4% | 13.4% | · | · | |
| Net Margin | 5.5% | 7.3% | 5.7% | 4.8% | 8.4% | 6.7% | 7.1% | 1.4% | · | · | |
| Pretax Margin | 9.9% | 11.9% | 9.7% | 8.3% | 13.1% | 11.4% | 10.5% | 9.2% | · | · | |
| EBITDA Margin | 20.2% | 21.9% | 19.3% | 17.8% | 21.2% | 20.0% | 19.7% | 18.4% | · | · | |
| ROA | 4.3% | 5.5% | 4.1% | 3.3% | 5.7% | 4.5% | 4.5% | 0.84% | 3.5% | 4.7% | |
| ROE | -281.8% | 159.1% | 78.2% | 76.4% | 91.5% | 44.0% | 27.8% | 3.8% | 14.2% | 18.5% | |
| ROIC | -245.6% | 1410.5% | 123.4% | 149.4% | 189.8% | 93.3% | 59.0% | 31.1% | 29.7% | 28.3% |
Liquidity & Solvency 2
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.3 | 1.3 | 1.2 | 1.2 | 1.3 | 1.3 | 1.6 | 1.7 | 2.9 | 1.5 | |
| Quick Ratio | 1.0 | 1.0 | 0.9 | 0.9 | 1.0 | 0.9 | 1.2 | 0.4 | 0.7 | 1.2 |
Efficiency 2
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.8 | 0.7 | 0.7 | 0.7 | 0.7 | 0.7 | 0.6 | 0.6 | · | · | |
| Receivables Turnover | 6.0 | 6.2 | 5.9 | 5.7 | 6.1 | 6.4 | 6.2 | 6.4 | · | · |
Growth Rates 9
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 6.5% | 5.6% | 4.6% | -0.08% | 0.59% | · | · | · | · | · | |
| Revenue CAGR 3Y | 5.5% | 3.3% | 1.7% | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 3.4% | · | · | · | · | · | · | · | · | · | |
| EPS YoY | -8.3% | 44.6% | 26.8% | -34.3% | 41.0% | · | · | · | · | · | |
| EPS CAGR 3Y | 18.9% | 6.4% | 5.5% | · | · | · | · | · | · | · | |
| EPS CAGR 5Y | 9.3% | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | -20.2% | 35.4% | 23.4% | -42.7% | 26.5% | · | · | · | · | · | |
| Net Income CAGR 3Y | 10.0% | -1.5% | -3.7% | · | · | · | · | · | · | · | |
| Net Income CAGR 5Y | -0.70% | · | · | · | · | · | · | · | · | · |
Valuation (TTM) 12
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $13.64B | $12.82B | $12.14B | $11.61B | $11.62B | $11.55B | $11.39B | $11.40B | $10.88B | $10.71B | |
| Net Income TTM | $747M | $936M | $692M | $560M | $978M | $774M | $811M | $159M | $664M | $880M | |
| Market Cap | $7.79B | $12.04B | $9.31B | $6.75B | $11.07B | $12.91B | $9.44B | $8.56B | $13.18B | $12.49B | |
| P/E | 11.5 | 13.9 | 14.1 | 12.8 | 12.8 | 18.6 | 14.2 | 55.9 | 20.8 | 15.0 | |
| P/S | 0.6 | 0.9 | 0.8 | 0.6 | 1.0 | 1.1 | 0.8 | 0.8 | 1.2 | 1.2 | |
| P/B | -12.0 | 99.4 | 8.8 | 9.5 | 14.6 | 9.3 | 4.4 | 2.3 | 2.8 | 2.7 | |
| P / Cash Flow | 4.1 | 6.0 | 4.5 | 4.3 | 5.7 | 6.5 | 4.6 | 4.8 | 6.9 | 6.4 | |
| P / FCF | 5.9 | 8.2 | 6.2 | 7.0 | 8.6 | 9.9 | 7.2 | 10.9 | 13.2 | 11.0 | |
| Dividend Yield | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | · | · | |
| Earnings Yield | 8.7% | 7.2% | 7.1% | 7.8% | 7.8% | 5.4% | 7.0% | 1.8% | 4.8% | 6.7% | |
| Payout Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | · | · | · | |
| Annual Payout | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | · | · |
Income Statement 13
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $3.55B | $3.42B | $3.62B | $3.42B | $3.38B | $3.22B | $3.29B | $3.26B | $3.19B | $3.07B | $3.15B | $3.12B | $3.00B | $2.87B | $2.92B | $2.95B | |
| SG&A Expense | $423M | $422M | $472M | $414M | $413M | $374M | $414M | $394M | $368M | $362M | $401M | $377M | $364M | $332M | $380M | $365M | |
| Operating Expenses | $2.98B | $2.93B | $3.06B | $2.91B | $2.84B | $2.78B | $2.73B | $2.73B | $2.68B | $2.59B | $2.76B | $2.63B | $2.60B | $2.56B | $2.66B | $2.64B | |
| Operating Income | $579M | $482M | $561M | $506M | $538M | $439M | $565M | $535M | $506M | $484M | $390M | $496M | $405M | $312M | $256M | $312M | |
| Other Non-op | $8M | $4M | $-21M | $-41M | $-23M | $-18M | $-13M | $-17M | $-27M | $-13M | $-5M | $-20M | $1M | $4M | $-8M | $-5M | |
| Pretax Income | $435M | $341M | $383M | $309M | $369M | $286M | $414M | $373M | $371M | $372M | $289M | $378M | $295M | $215M | $147M | $207M | |
| Income Tax | $92M | $66M | $77M | $69M | $94M | $54M | $64M | $78M | $72M | $66M | $58M | $69M | $49M | $44M | $34M | $43M | |
| Net Income | $265M | $198M | $234M | $150M | $199M | $163M | $259M | $215M | $223M | $240M | $151M | $247M | $179M | $116M | $68M | $105M | |
| EPS (Basic) | $4.10 | $2.93 | $3.30 | $2.09 | $2.62 | $2.05 | $3.17 | $2.56 | $2.56 | $2.73 | $1.68 | $2.70 | $1.96 | $1.28 | $0.81 | $1.16 | |
| EPS (Diluted) | $4.02 | $2.87 | $3.22 | $2.04 | $2.58 | $2.00 | $3.08 | $2.50 | $2.50 | $2.65 | $1.64 | $2.62 | $1.91 | $1.25 | $0.81 | $1.13 | |
| Shares (Basic) | 64,781,000 | 67,390,000 | -153,159,000 | 72,075,000 | 75,943,000 | 79,368,000 | -173,404,000 | 83,721,000 | 86,899,000 | 87,775,000 | -182,013,000 | 91,322,000 | 90,984,000 | 90,497,000 | -188,967,000 | 91,160,000 | |
| Shares (Diluted) | 66,092,000 | 68,875,000 | -156,521,000 | 73,769,000 | 77,362,000 | 81,275,000 | -178,018,000 | 85,795,000 | 88,950,000 | 90,547,000 | -186,760,000 | 94,041,000 | 93,418,000 | 92,483,000 | -195,704,000 | 93,263,000 | |
| EBITDA | $579M | $660M | · | $506M | $538M | $615M | · | $535M | $506M | $671M | · | $496M | $405M | $490M | · | $312M |
Balance Sheet 26
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $669M | $644M | $676M | $706M | $708M | $439M | $795M | $1.07B | $416M | $345M | · | $449M | $327M | $317M | · | $368M | |
| Short-term Investments | $20M | $22M | $24M | $31M | $31M | $73M | $51M | $21M | $21M | $11M | · | $12M | $12M | $50M | · | $74M | |
| Receivables | $2.47B | $2.46B | $2.41B | $2.33B | $2.44B | $2.32B | $2.15B | $2.27B | $2.30B | $2.59B | · | $2.02B | $2.01B | $2.06B | · | $2.09B | |
| Inventory | $152M | $142M | $161M | $139M | $146M | $151M | $135M | $129M | $127M | $146M | · | $110M | $110M | $107M | · | $107M | |
| Prepaid Expense | $149M | $160M | $156M | $161M | $110M | $130M | $123M | $97M | $83M | $105M | · | $91M | $90M | $89M | · | $66M | |
| Current Assets | $4.19B | $4.06B | $4.06B | $4.11B | $4.09B | $3.64B | $3.75B | $4.04B | $3.47B | $3.68B | · | $3.14B | $3.00B | $3.04B | · | $3.20B | |
| PP&E (Net) | $2.75B | $2.75B | $2.81B | $2.85B | $2.85B | $2.90B | $2.94B | $2.94B | $2.98B | $3.03B | · | $3.10B | $3.16B | $3.22B | · | $3.24B | |
| PP&E (Gross) | · | · | $9.42B | · | · | · | $9.20B | · | · | · | · | · | · | · | · | · | |
| Accum. Depreciation | $6.87B | · | $6.60B | · | · | · | $6.26B | · | · | · | · | · | · | · | · | · | |
| Goodwill | $7.59B | $7.58B | $7.55B | $7.54B | $7.47B | $7.42B | $7.38B | $7.23B | $7.20B | $7.23B | $7.11B | $7.09B | $7.11B | $7.09B | $7.08B | $7.02B | |
| Intangibles | $229M | $229M | $222M | $220M | $212M | $205M | $197M | $198M | $191M | $201M | · | $185M | $192M | $187M | · | $180M | |
| Other Non-current Assets | $299M | $267M | $247M | $204M | $193M | $239M | $262M | $219M | $240M | $262M | · | $302M | $314M | $291M | · | $308M | |
| Total Assets | $17.71B | $17.50B | $17.48B | $17.56B | $17.49B | $17.12B | $17.29B | $17.50B | $17.03B | $17.43B | · | $16.93B | $16.96B | $16.73B | · | $16.96B | |
| Accounts Payable | $716M | $691M | $696M | $656M | $594M | $596M | $547M | $488M | $494M | $490M | · | $435M | $428M | $448M | · | $417M | |
| Current Liabilities | $2.86B | $2.87B | $3.14B | $3.02B | $2.93B | $2.91B | $2.97B | $2.94B | $2.99B | $2.58B | · | $2.54B | $2.40B | $2.57B | · | $2.54B | |
| Capital Leases | $2.19B | $2.16B | $2.18B | $2.10B | $2.12B | $2.16B | $2.21B | $2.24B | $2.28B | $2.31B | · | $2.34B | $2.38B | $2.46B | · | $2.56B | |
| Deferred Tax | $826M | $819M | $757M | $742M | $646M | $665M | $665M | $660M | $694M | $720M | · | $754M | $760M | $771M | · | $819M | |
| Other Non-current Liabilities | $99M | $89M | $84M | $172M | $156M | $167M | $170M | $183M | $179M | $180M | · | $185M | $183M | $100M | · | $107M | |
| Total Liabilities | $16.63B | $16.45B | $16.32B | $16.22B | $15.94B | $15.46B | $15.19B | $15.28B | $14.60B | $14.79B | · | $14.10B | $14.33B | $14.31B | · | $14.89B | |
| Common Stock | $69.0K | $69.0K | $69.0K | $91.0K | $91.0K | $91.0K | $90.0K | $90.0K | $90.0K | $90.0K | · | $91.0K | $91.0K | $91.0K | · | $98.0K | |
| Retained Earnings | $81M | $-179M | $-328M | $2.05B | $1.90B | $1.70B | $1.53B | $1.28B | $1.06B | $838M | · | $715M | $469M | $290M | · | $847M | |
| Treasury Stock | $788M | $489M | $200M | $2.90B | $2.49B | $2.04B | $1.39B | $1.02B | $616M | $240M | · | · | · | · | · | $788M | |
| AOCI | $-59M | $-87M | $-123M | $-116M | $-138M | $-227M | $-311M | $-162M | $-195M | $-100M | · | $-69M | $-7M | $-55M | · | $-136M | |
| Stockholders' Equity | $-765M | $-755M | $-651M | $-572M | $-370M | $-267M | $121M | $387M | $633M | $926M | · | $1.20B | $1.02B | $825M | · | $533M | |
| Liabilities + Equity | $17.71B | $17.50B | $17.48B | $17.56B | $17.49B | $17.12B | $17.29B | $17.50B | $17.03B | $17.43B | · | $16.93B | $16.96B | $16.73B | · | $16.96B | |
| Shares Outstanding | 63,955,000 | 69,190,000 | 68,549,000 | 70,977,000 | 74,217,000 | 77,277,000 | 80,536,000 | 82,624,000 | 85,081,000 | 89,822,000 | 88,824,000 | 91,348,000 | 91,271,000 | 90,650,000 | 90,411,000 | 90,104,000 |
Cash Flow 14
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $168M | $178M | $180M | $177M | $175M | $176M | $167M | $187M | $176M | $187M | $186M | $188M | $184M | $178M | $183M | $194M | |
| Stock-based Comp | $26M | $28M | $38M | $39M | $33M | $30M | $27M | $27M | $24M | $25M | $30M | $27M | $30M | $25M | $18M | $28M | |
| Deferred Tax | $-1M | $55M | $18M | $79M | $-14M | $4M | $-4M | $-25M | $-25M | $-3M | $-22M | $-2M | $-13M | $-4M | $-40M | $-45M | |
| Other Non-cash | · | $-137M | · | · | · | $-193M | · | · | · | $-583M | · | · | · | $147M | · | · | |
| Operating Cash Flow | $490M | $321M | $541M | $842M | $324M | $180M | $548M | $810M | $799M | $-135M | $485M | $661M | $450M | $463M | $344M | $711M | |
| CapEx | $170M | $102M | $145M | $166M | $121M | $143M | $171M | $139M | $125M | $121M | $159M | $137M | $124M | $148M | $194M | $144M | |
| Investing Cash Flow | $-194M | $-139M | $-163M | $-263M | $-67M | $-162M | $-248M | $-146M | $-162M | $-215M | $-168M | $-140M | $-347M | $-117M | $-213M | $-154M | |
| Debt Issued | $1.51B | $1.26B | $940M | $482M | $3.56B | $633M | $676.0K | $3.35B | $1.99B | $1.29B | $6.0K | $331M | $1.53B | $612M | $687M | $523M | |
| Net Debt Issued | · | $1.26B | · | · | · | $633M | · | · | · | $1.29B | · | · | · | $612M | · | · | |
| Stock Repurchased | $181M | $196M | $274M | $240M | $284M | $510M | $365M | $408M | $362M | $251M | $272M | $0 | $0 | $0 | $0 | $185M | |
| Net Stock Activity | · | $-196M | · | · | · | $-510M | · | · | · | $-251M | · | · | · | $0 | · | · | |
| Financing Cash Flow | $-270M | $-213M | $-415M | $-582M | $4M | $-383M | $-565M | $-8M | $-563M | $319M | $-403M | $-395M | $-97M | $-276M | $-231M | $-445M | |
| Net Change in Cash | $25M | $-31M | $-38M | $-2M | $272M | $-355M | $-279M | $655M | $72M | $-34M | $-80M | $123M | $11M | $72M | $-123M | $106M | |
| Free Cash Flow | · | $219M | · | · | · | $37M | · | · | · | $-256M | · | · | · | $315M | · | · |
Profitability 7
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 16.3% | 14.1% | · | 14.8% | 15.9% | 13.6% | · | 16.4% | 15.9% | 15.8% | · | 15.9% | 13.5% | 10.8% | · | 10.6% | |
| Net Margin | 7.5% | 5.8% | · | 4.4% | 5.9% | 5.1% | · | 6.6% | 7.0% | 7.8% | · | 7.9% | 6.0% | 4.0% | · | 3.6% | |
| Pretax Margin | 12.2% | 10.0% | · | 9.0% | 10.9% | 8.9% | · | 11.4% | 11.7% | 12.1% | · | 12.1% | 9.8% | 7.5% | · | 7.0% | |
| EBITDA Margin | 16.3% | 19.3% | · | 14.8% | 15.9% | 19.1% | · | 16.4% | 15.9% | 21.9% | · | 15.9% | 13.5% | 17.1% | · | 10.6% | |
| ROA | 1.5% | 1.1% | · | 0.86% | 1.1% | 0.94% | · | 1.2% | 1.3% | 1.4% | · | 1.5% | 1.1% | 0.68% | · | 0.61% | |
| ROE | -46.8% | -38.6% | · | -162.4% | 151.4% | 49.5% | · | 27.1% | 27.0% | 27.4% | · | 28.5% | 22.0% | 13.8% | · | 12.5% | |
| ROIC | -59.7% | -51.4% | · | -68.8% | -108.5% | -133.3% | · | 109.5% | 64.6% | 43.0% | · | 33.8% | 33.2% | 30.0% | · | 46.5% |
Liquidity & Solvency 2
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.5 | 1.4 | · | 1.4 | 1.4 | 1.3 | · | 1.4 | 1.2 | 1.4 | · | 1.2 | 1.2 | 1.2 | · | 1.3 | |
| Quick Ratio | 1.1 | 1.1 | · | 1.0 | 1.1 | 1.0 | · | 1.1 | 0.9 | 1.1 | · | 1.0 | 1.0 | 0.9 | · | 1.0 |
Efficiency 2
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.2 | · | 0.2 | |
| Receivables Turnover | 1.4 | 1.4 | · | 1.5 | 1.4 | 1.3 | · | 1.5 | 1.5 | 1.3 | · | 1.5 | 1.5 | 1.4 | · | 1.4 |
Valuation (TTM) 9
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $13.77B | $13.44B | · | $13.29B | $13.05B | $12.74B | · | $12.64B | $12.38B | $12.06B | · | $11.94B | $11.75B | $11.57B | · | $11.63B | |
| Net Income TTM | $813M | $710M | · | $727M | $800M | $840M | · | $924M | $888M | $781M | · | $646M | $624M | $608M | · | $752M | |
| Market Cap | $14.23B | $10.63B | · | $9.43B | $10.57B | $11.82B | · | $13.54B | $11.79B | $12.40B | · | $8.64B | $9.17B | $7.35B | · | $7.46B | |
| P/E | 19.3 | 16.2 | · | 14.6 | 14.9 | 15.9 | · | 16.0 | 14.3 | 16.4 | · | 13.7 | 15.2 | 12.9 | · | 11.2 | |
| P/S | 1.0 | 0.8 | · | 0.7 | 0.8 | 0.9 | · | 1.1 | 1.0 | 1.0 | · | 0.7 | 0.8 | 0.6 | · | 0.6 | |
| P/B | -18.6 | -14.1 | · | -16.5 | -28.6 | -44.3 | · | 35.0 | 18.6 | 13.4 | · | 7.2 | 9.0 | 8.9 | · | 14.0 | |
| P / Cash Flow | · | 33.1 | · | · | · | 65.7 | · | · | · | -92.0 | · | · | · | 15.9 | · | · | |
| P / FCF | · | 48.6 | · | · | · | 321.7 | · | · | · | -48.5 | · | · | · | 23.4 | · | · | |
| Earnings Yield | 5.2% | 6.2% | · | 6.9% | 6.7% | 6.3% | · | 6.3% | 7.0% | 6.1% | · | 7.3% | 6.6% | 7.8% | · | 8.9% |
Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years
Income Statement
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Revenue | $13.64B | $12.82B | $12.14B | $11.61B | $11.62B |
| Operating Margin % | 15.0% | 16.3% | 13.2% | 11.5% | 15.5% |
| Net Income | $747M | $936M | $692M | $560M | $978M |
| Diluted EPS | $9.84 | $10.73 | $7.42 | $5.85 | $8.90 |
Balance Sheet
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Current Ratio | 1.3 | 1.3 | 1.2 | 1.2 | 1.3 |
| Quick Ratio | 1.0 | 1.0 | 0.9 | 0.9 | 1.0 |
Cash Flow
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Free Cash Flow | $1.31B | $1.47B | $1.49B | $961M | $1.29B |
Trading Signals Recent buy/sell signals with entry price and risk/reward ratio
My Metrics Your personal watchlist — selected rows from Full Fundamentals
📊
Pick the metrics that matter to you — click the ➕ next to any row in Full Fundamentals above.
Your selection is saved and follows you across all tickers.
Institutional owners (13F) 696 filers · $7.9B total · As of June 30, 2026
Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.
Institutional activity — Q2 2026 vs prior quarter
| New positions | Exited positions | Increased | Decreased | Net shares change |
|---|---|---|---|---|
| 131 (-1 vs prior Q) | 59 (-5 vs prior Q) | 184 (+11 vs prior Q) | 217 (+12 vs prior Q) | +3.7M |
Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.
| Institution | Value | Shares | % of tracked 13F | Type |
|---|---|---|---|---|
| Berkshire Hathaway Inc | $3,331,328,308 | 14,973,608 | 42.04% | Shares |
| VANGUARD CAPITAL MANAGEMENT LLC | $467,525,034 | 2,101,425 | 5.90% | Shares |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $306,558,307 | 1,377,914 | 3.87% | Shares |
| STATE STREET CORP | $294,345,267 | 1,323,019 | 3.71% | Shares |
| DIMENSIONAL FUND ADVISORS LP | $235,869,514 | 1,060,183 | 2.98% | Shares |
| NEUBERGER BERMAN GROUP LLC | $199,315,922 | 896,621 | 2.52% | Shares |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $197,802,963 | 889,082 | 2.50% | Shares |
| GEODE CAPITAL MANAGEMENT, LLC | $165,824,664 | 746,907 | 2.09% | Shares |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $163,166,832 | 733,400 | 2.06% | Call option |
| Gates Capital Management, Inc. | $153,096,497 | 688,136 | 1.93% | Shares |
| BANK OF AMERICA CORP /DE/ | $133,302,007 | 599,164 | 1.68% | Shares |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $81,331,791 | 365,569 | 1.03% | Shares |
| NORGES BANK | $76,627,007 | 344,422 | 0.97% | Shares |
| NORDEA INVESTMENT MANAGEMENT AB | $67,404,554 | 305,067 | 0.85% | Shares |
| GOLDMAN SACHS GROUP INC | $63,752,756 | 286,555 | 0.80% | Shares |
| D. E. Shaw & Co., Inc. | $62,040,995 | 278,861 | 0.78% | Shares |
| JANE STREET GROUP, LLC | $53,573,184 | 240,800 | 0.68% | Call option |
| Holocene Advisors, LP | $52,875,709 | 237,665 | 0.67% | Shares |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $48,100,176 | 216,200 | 0.61% | Put option |
| Quantinno Capital Management LP | $45,366,106 | 203,910 | 0.57% | Shares |
| CITADEL ADVISORS LLC | $44,465,298 | 199,862 | 0.56% | Shares |
| CITADEL ADVISORS LLC | $44,184,528 | 198,600 | 0.56% | Call option |
| VANGUARD FIDUCIARY TRUST CO | $40,134,502 | 180,396 | 0.51% | Shares |
| WEDGE CAPITAL MANAGEMENT L L P/NC | $37,089,700 | 241,328 | 0.47% | Shares |
| Gotham Asset Management, LLC | $36,393,278 | 163,580 | 0.46% | Shares |
| JANE STREET GROUP, LLC | $35,774,784 | 160,800 | 0.45% | Put option |
| Doma Perpetual Capital Management LLC | $35,522,937 | 159,668 | 0.45% | Shares |
| FIRST TRUST ADVISORS LP | $34,161,205 | 153,548 | 0.43% | Shares |
| TODD ASSET MANAGEMENT LLC | $32,697,663 | 146,969 | 0.41% | Shares |
| LOS ANGELES CAPITAL MANAGEMENT LLC | $32,011,312 | 143,884 | 0.40% | Shares |
| Allianz Asset Management GmbH | $30,236,367 | 135,906 | 0.38% | Shares |
| MORGAN STANLEY | $28,624,054 | 128,659 | 0.36% | Shares |
| Toroso Investments, LLC | $28,283,664 | 248,954 | 0.36% | Shares |
| CANADA PENSION PLAN INVESTMENT BOARD | $26,480,460 | 119,024 | 0.33% | Shares |
| BlackRock, Inc. | $26,457,544 | 118,921 | 0.33% | Shares |
| VICTORY CAPITAL MANAGEMENT INC | $26,377,896 | 118,563 | 0.33% | Shares |
| Amundi | $25,967,198 | 116,717 | 0.33% | Shares |
| BARCLAYS PLC | $25,933,826 | 116,567 | 0.33% | Shares |
| Davidson Kempner Capital Management LP | $25,162,043 | 113,098 | 0.32% | Shares |
| ENVESTNET ASSET MANAGEMENT INC | $23,582,658 | 105,999 | 0.30% | Shares |
| VANGUARD GROUP INC | $23,117,136 | 203,478 | 0.29% | Shares |
| RHUMBLINE ADVISERS | $23,076,629 | 103,725 | 0.29% | Shares |
| Woodline Partners LP | $22,872,501 | 102,807 | 0.29% | Shares |
| UBS Group AG | $20,846,376 | 93,700 | 0.26% | Put option |
| MILLENNIUM MANAGEMENT LLC | $20,579,400 | 92,500 | 0.26% | Put option |
| FMR LLC | $20,183,608 | 90,721 | 0.25% | Shares |
| SCHRODER INVESTMENT MANAGEMENT GROUP | $19,532,854 | 87,796 | 0.25% | Shares |
| MILLENNIUM MANAGEMENT LLC | $17,151,873 | 77,094 | 0.22% | Shares |
| California Public Employees Retirement System | $15,370,253 | 69,086 | 0.19% | Shares |
| Swiss National Bank | $14,906,160 | 67,000 | 0.19% | Shares |
| Vanguard Global Advisers, LLC | $14,696,806 | 66,059 | 0.19% | Shares |
| WOLVERINE TRADING, LLC | $14,482,431 | 110,900 | 0.18% | Put option |
| National Philanthropic Trust | $14,000,889 | 62,931 | 0.18% | Shares |
| PineBridge Investments, L.P. | $13,874,153 | 104,419 | 0.18% | Shares |
| TUDOR INVESTMENT CORP ET AL | $13,325,440 | 59,895 | 0.17% | Shares |
| BNP PARIBAS FINANCIAL MARKETS | $13,022,644 | 58,534 | 0.16% | Shares |
| Candriam S.C.A. | $12,727,615 | 57,263 | 0.16% | Shares |
| DANSKE BANK A/S | $12,471,116 | 56,055 | 0.16% | Shares |
| CITADEL ADVISORS LLC | $12,280,896 | 55,200 | 0.15% | Put option |
| Susquehanna Portfolio Strategies, LLC | $12,219,714 | 54,925 | 0.15% | Shares |
| MILLENNIUM MANAGEMENT LLC | $11,902,680 | 53,500 | 0.15% | Call option |
| STOREBRAND ASSET MANAGEMENT AS | $11,500,659 | 51,693 | 0.15% | Shares |
| LPL Financial LLC | $10,778,934 | 48,449 | 0.14% | Shares |
| Robeco Institutional Asset Management B.V. | $10,083,684 | 45,324 | 0.13% | Shares |
| Callahan Advisors, LLC | $10,033,403 | 45,098 | 0.13% | Shares |
| Assenagon Asset Management S.A. | $9,963,322 | 44,783 | 0.13% | Shares |
| Verition Fund Management LLC | $9,740,174 | 43,780 | 0.12% | Shares |
| Prospera Financial Services Inc | $9,482,479 | 42,623 | 0.12% | Shares |
| Te Ahumairangi Investment Management Ltd | $9,480,318 | 42,612 | 0.12% | Shares |
| SEI INVESTMENTS CO | $9,251,830 | 41,585 | 0.12% | Shares |
| Connor, Clark & Lunn Investment Management Ltd. | $9,207,557 | 41,386 | 0.12% | Shares |
| Inlet Private Wealth, LLC | $9,004,878 | 40,475 | 0.11% | Shares |
| Mitsubishi UFJ Asset Management Co., Ltd. | $8,835,126 | 39,712 | 0.11% | Shares |
| Caisse de depot et placement du Quebec | $8,721,216 | 39,200 | 0.11% | Shares |
| Twin Tree Management, LP | $8,454,240 | 38,000 | 0.11% | Call option |
| Brevan Howard Capital Management LP | $8,343,000 | 37,500 | 0.11% | Call option |
| CITIGROUP INC | $8,298,504 | 37,300 | 0.10% | Put option |
| NISA INVESTMENT ADVISORS, LLC | $7,947,431 | 35,722 | 0.10% | Shares |
| IEQ CAPITAL, LLC | $7,900,154 | 35,510 | 0.10% | Shares |
| UBS Group AG | $7,386,336 | 33,200 | 0.09% | Call option |
| Counterpoint Mutual Funds LLC | $7,384,111 | 33,190 | 0.09% | Shares |
| VANGUARD ASSET MANAGEMENT, Ltd | $7,170,308 | 32,229 | 0.09% | Shares |
| FIFTH THIRD BANCORP | $7,074,159 | 31,797 | 0.09% | Shares |
| Summit Trail Advisors, LLC | $7,043,272 | 31,658 | 0.09% | Shares |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | $6,953,397 | 45,243 | 0.09% | Shares |
| Corient Private Wealth LP | $6,916,838 | 31,117 | 0.09% | Shares |
| Tredje AP-fonden | $6,780,968 | 30,479 | 0.09% | Shares |
| STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM | $6,656,824 | 29,921 | 0.08% | Shares |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $6,539,132 | 29,392 | 0.08% | Shares |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $6,407,202 | 28,799 | 0.08% | Shares |
| NATIONAL BANK OF CANADA /FI/ | $6,204,782 | 27,888 | 0.08% | Shares |
| Walleye Capital LLC | $6,184,944 | 27,800 | 0.08% | Call option |
| GHP Investment Advisors, Inc. | $6,107,487 | 39,739 | 0.08% | Shares |
| Wakefield Asset Management LLLP | $5,893,051 | 26,488 | 0.07% | Shares |
| STATE OF WISCONSIN INVESTMENT BOARD | $5,749,551 | 25,843 | 0.07% | Shares |
| ALLIANCEBERNSTEIN L.P. | $5,566,805 | 36,221 | 0.07% | Shares |
| NEW YORK STATE COMMON RETIREMENT FUND | $5,507,937 | 24,757 | 0.07% | Shares |
| CWA Asset Management Group, LLC | $5,003,575 | 22,490 | 0.06% | Shares |
| Legal & General Group Plc | $4,992,452 | 22,440 | 0.06% | Shares |
| Mitsubishi UFJ Trust & Banking Corp | $4,942,393 | 22,215 | 0.06% | Shares |
Company insiders 59 insiders · 31 officers · 25 directors
| Insider | Role | Last activity | Shares owned | Buys 12m | Sells 12m | Net 12m |
|---|---|---|---|---|---|---|
| Javier Rodriguez | Chief Executive Officer | June 16, 2026 S | 840,408 | 0 | 2 | $-14,532,097 |
| Dennis Kogod | Pres, HCP & CEO, DVA Int. | May 17, 2016 S | 18,766 | 0 | 0 | $0 |
| Joel Ackerman | CFO and Treasurer | May 7, 2026 S | 132,434 | 0 | 1 | $-9,887,579 |
| Luis Borgen | Chief Financial Officer | March 22, 2012 M | 18,517 | 0 | 0 | $0 |
| Richard K Whitney | Chief Financial Officer | March 31, 2010 A | 33,604 | 0 | 0 | $0 |
| Mark G Harrison | Chief Financial Officer | March 14, 2007 A | 31,250 | 0 | 0 | $0 |
| Gary Beil | Acting Chief Financial Officer | July 1, 2006 A | 10,000 | 0 | 0 | $0 |
| David Paul Maughan | Chief Operating Officer, DKC | May 12, 2026 S | 94,105 | 0 | 2 | $-4,089,696 |
| Michael David Staffieri | Chief Operating Officer, DKC | Aug. 16, 2024 S | 209,365 | 0 | 0 | $0 |
| Joseph C Mello | COO, HCP | Dec. 24, 2016 A | 4,688 | 0 | 0 | $0 |
| Kathleen Alyce Waters | Chief Legal & Pub. Affairs Off | June 15, 2026 S | 109,194 | 0 | 2 | $-3,210,360 |
| James O Hearty | Chief Compliance Officer | May 14, 2026 M | 22,389 | 0 | 2 | $-3,291,616 |
| Christopher Michael Berry | Chief Accounting Officer | March 15, 2026 A | 19,640 | 0 | 0 | $0 |
| John D Winstel | Chief Accounting Officer | March 15, 2023 F | 15,676 | 0 | 0 | $0 |
| Leanne M Zumwalt | Group VP, Government Affairs | Sept. 18, 2020 M | 24,590 | 0 | 0 | $0 |
| Kent J Thiry | Executive Chairman | June 1, 2020 F | 110,462 | 0 | 0 | $0 |
| James K Hilger | Chief Accounting Officer | June 2, 2019 F | 33,125 | 0 | 0 | $0 |
| Jeanine Marie Jiganti | Chief Compliance Officer | June 13, 2017 M | 3,514 | 0 | 0 | $0 |
| Kim M Rivera | Chief Legal Officer | Sept. 22, 2015 M | 7,438 | 0 | 0 | $0 |
| Robert J Margolis | Co-Chairman of the Board | June 4, 2015 S | 2,322,928 | 0 | 0 | $0 |
| Allen Nissenson | Chief Medical Officer | Feb. 13, 2014 M | 8,990 | 0 | 0 | $0 |
| Garry E Menzel | Senior Vice President, Finance | Sept. 9, 2013 A | — | 0 | 0 | $0 |
| David T Shapiro | Chief Special Counsel | Aug. 2, 2013 G | 2,315 | 0 | 0 | $0 |
| Thomas O Usilton | Senior Vice President | Feb. 29, 2012 M | 17,491 | 0 | 0 | $0 |
| Georgina Randolph | Senior Vice President | June 17, 2009 M | 5,547 | 0 | 0 | $0 |
| Joseph Schohl | VP, Gen. Counsel & Secretary | Feb. 13, 2009 M | 2,084 | 0 | 0 | $0 |
| Christopher J Riopelle | Chief Compliance Officer | Aug. 11, 2008 M | 2,500 | 0 | 0 | $0 |
| Mary Kowenhoven | Vice President - Strategy | March 5, 2008 A | — | 0 | 0 | $0 |
| Patricia Jones | Chief People Officer | July 16, 2007 A | 6,250 | 0 | 0 | $0 |
| Charles J Mcallister | Chief Medical Officer | May 8, 2007 M | 999 | 0 | 0 | $0 |
| Thomas L Kelly | Executive Vice President | Nov. 4, 2005 M | 42,000 | 0 | 0 | $0 |
| Dennis W Pullin | Director | Aug. 15, 2026 A | 2,949 | 0 | 0 | $0 |
| Gregory J. Moore | Director | Aug. 15, 2026 A | 8,091 | 0 | 0 | $0 |
| Jason M. Hollar | Director | Aug. 15, 2026 A | 6,883 | 0 | 0 | $0 |
| Patricia M Arway | Director | Aug. 15, 2026 A | 27,223 | 0 | 0 | $0 |
| Adam H Schechter | Director | Aug. 15, 2026 A | 5,970 | 0 | 0 | $0 |
| Wendy Lee Schoppert | Director | Aug. 15, 2026 A | 278 | 0 | 0 | $0 |
| Phyllis R Yale | Director | Aug. 15, 2026 A | 9,803 | 0 | 0 | $0 |
| Barbara J Desoer | Director | Aug. 15, 2026 A | 278 | 0 | 0 | $0 |
| Charles Berg | Director | May 15, 2025 A | 19,982 | 0 | 0 | $0 |
| John M Nehra | Director | May 15, 2024 A | 363 | 0 | 0 | $0 |
| Paul J Diaz | Director | May 15, 2023 A | 16,069 | 0 | 0 | $0 |
| Paula A Price | Director | May 15, 2022 A | 1,395 | 0 | 0 | $0 |
| Shawn M Guertin | Director | May 15, 2021 A | 1,105 | 0 | 0 | $0 |
| Pascal Desroches | Director | Nov. 15, 2020 A | 8,030 | 0 | 0 | $0 |
| William L Roper | Director | June 11, 2020 A | 16,234 | 0 | 0 | $0 |
| Peter T Grauer | Director | June 11, 2020 A | 76,204 | 0 | 0 | $0 |
| Carol Anthony Davidson | Director | Dec. 31, 2017 A | 10,764 | 0 | 0 | $0 |
| Willard Woodson Brittain JR | Director | June 11, 2012 A | 7,195 | 0 | 0 | $0 |
| Richard C Vaughan | Director | May 13, 2010 A | 6,092 | 0 | 0 | $0 |
Insiders from SEC Form 3/4/5 filings; net = open-market P/S only
Activists & 5%+ owners 1 position
Investors who filed SEC Schedule 13D — beneficial ownership above 5% with an intent to influence the issuer (activist stakes, board campaigns, M&A). Each row shows the most recent known state of that filer's position.
| Filer | Filed | Stake | Status | Purpose | Filing |
|---|---|---|---|---|---|
| Warren E. Buffett, Berkshire Hathaway Inc., National Indemnity Company, GEICO Corporation, Government Employees Insurance Company, Berkshire Hathaway Consolidated Pension Plan Master Trust, BNSF Master Retirement Trust, Scott Fetzer Company Collective Investment Trust, R. Ted Weschler ×13 filings | Feb. 13, 2025 | 45.00% | Amendment | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
ETF ownership Held by 130 ETFs
Weight reflects direct equity holdings (N-PORT) only; leveraged or derivative-based funds may hold additional swap exposure not shown.
| Fund | Weight | Units | As of | Source |
|---|---|---|---|---|
| OMAH · Tidal Trust III | 4.50% | 217,039 NS | April 30, 2026 | N-PORT |
| AZTD · Tidal Trust I | 2.74% | 7,761 NS | April 30, 2026 | N-PORT |
| FXH · First Trust Exchange-Traded AlphaDE… | 2.19% | 123,121 NS | April 30, 2026 | N-PORT |
| RSPH · Invesco Exchange-Traded Fund Trust | 1.40% | 59,690 SH | Aug. 8, 2026 | Daily |
| AGNG · Global X Funds | 0.92% | 3,855 NS | May 31, 2026 | N-PORT |
| IHF · iShares Trust | 0.86% | 58,907 SH | Aug. 8, 2026 | Daily |
| LSEQ · Harbor ETF Trust | 0.76% | 758 NS | April 30, 2026 | N-PORT |
| SIXL · EXCHANGE TRADED CONCEPTS TRUST | 0.56% | 5,441 NS | May 31, 2026 | N-PORT |
| ITAN · EA Series Trust | 0.38% | 1,735 NS | May 29, 2026 | N-PORT |
| JPME · J.P. Morgan Exchange-Traded Fund Tr… | 0.38% | 10,626 NS | April 30, 2026 | N-PORT |
| AFLG · First Trust Exchange-Traded Fund VI… | 0.34% | 11,220 NS | May 31, 2026 | N-PORT |
| VFMF · VANGUARD WELLINGTON FUND | 0.31% | 9,914 SH | Aug. 8, 2026 | Daily |
| AFMC · First Trust Exchange-Traded Fund VI… | 0.30% | 2,502 NS | May 31, 2026 | N-PORT |
| JMID · Janus Detroit Street Trust | 0.30% | 352 NS | April 30, 2026 | N-PORT |
| VGHY · VANGUARD FIXED INCOME SECURITIES FU… | 0.28% | 909,000 PA | Aug. 8, 2026 | Daily |
| DFVE · DoubleLine ETF Trust | 0.24% | 425 NS | March 31, 2026 | N-PORT |
| PKW · Invesco Exchange-Traded Fund Trust | 0.24% | 22,988 SH | Aug. 8, 2026 | Daily |
| IQSM · New York Life Investments ETF Trust | 0.23% | 4,682 NS | April 30, 2026 | N-PORT |
| ROSC · Lattice Strategies Trust | 0.18% | 635 NS | April 30, 2026 | N-PORT |
| RSP · Invesco Exchange-Traded Fund Trust | 0.17% | 934,012 SH | Aug. 8, 2026 | Daily |
| VBR · VANGUARD INDEX FUNDS | 0.15% | 467,367 SH | Aug. 8, 2026 | Daily |
| BKMC · BNY Mellon ETF Trust | 0.14% | 5,728 NS | April 30, 2026 | N-PORT |
| FNK · First Trust Exchange-Traded AlphaDE… | 0.14% | 1,975 NS | April 30, 2026 | N-PORT |
| DFAS · Dimensional ETF Trust | 0.14% | 124,181 NS | April 30, 2026 | N-PORT |
| JPUS · J.P. Morgan Exchange-Traded Fund Tr… | 0.13% | 3,564 NS | April 30, 2026 | N-PORT |
| SCHM · SCHWAB STRATEGIC TRUST | 0.12% | 90,512 NS | May 31, 2026 | N-PORT |
| VHT · VANGUARD WORLD FUND | 0.11% | 100,394 SH | Aug. 8, 2026 | Daily |
| ISCG · iShares Trust | 0.11% | 6,082 SH | Aug. 8, 2026 | Daily |
| BBMC · J.P. Morgan Exchange-Traded Fund Tr… | 0.11% | 14,233 NS | April 30, 2026 | N-PORT |
| ESML · iShares Trust | 0.10% | 15,995 SH | Aug. 8, 2026 | Daily |
| FHLC · FIDELITY COVINGTON TRUST | 0.10% | 17,983 NS | April 30, 2026 | N-PORT |
| ISCB · iShares Trust | 0.10% | 1,555 SH | Aug. 8, 2026 | Daily |
| IYH · iShares Trust | 0.09% | 19,255 SH | Aug. 8, 2026 | Daily |
| RXL · ProShares Trust | 0.09% | 348 NS | May 31, 2026 | N-PORT |
| ISCV · iShares Trust | 0.09% | 3,622 SH | Aug. 8, 2026 | Daily |
| VB · VANGUARD INDEX FUNDS | 0.09% | 736,199 SH | Aug. 8, 2026 | Daily |
| SMMD · iShares Trust | 0.08% | 16,234 SH | Aug. 8, 2026 | Daily |
| EQAL · Invesco Exchange-Traded Fund Trust … | 0.08% | 3,527 SH | Aug. 8, 2026 | Daily |
| CURE · Direxion Shares ETF Trust | 0.07% | 667 NS | April 30, 2026 | N-PORT |
| IXJ · iShares Trust | 0.07% | 16,934 SH | Aug. 8, 2026 | Daily |
| SMMV · iShares Trust | 0.07% | 1,125 SH | Aug. 8, 2026 | Daily |
| FNX · First Trust Exchange-Traded AlphaDE… | 0.07% | 5,907 NS | April 30, 2026 | N-PORT |
| AVMC · AMERICAN CENTURY ETF TRUST | 0.07% | 1,423 NS | May 31, 2026 | N-PORT |
| DEUS · DBX ETF Trust | 0.07% | 930 NS | May 29, 2026 | N-PORT |
| RWL · Invesco Exchange-Traded Fund Trust … | 0.06% | 33,893 SH | Aug. 8, 2026 | Daily |
| IUS · Invesco Exchange-Traded Self-Indexe… | 0.06% | 3,136 SH | Aug. 8, 2026 | Daily |
| WSML · iShares Trust | 0.05% | 1,985 SH | Aug. 8, 2026 | Daily |
| TILT · FlexShares Trust | 0.05% | 6,930 NS | April 30, 2026 | N-PORT |
| IWS · iShares Trust | 0.05% | 45,847 SH | Aug. 8, 2026 | Daily |
| DUHP · Dimensional ETF Trust | 0.04% | 32,462 NS | April 30, 2026 | N-PORT |